Literature DB >> 18083642

Immersion behavior of gelatin-containing calcium phosphate cement.

Ming-You Shie1, David Chan-Hen Chen, Chuan-Yeh Wang, Ting-Yi Chiang, Shinn-Jyh Ding.   

Abstract

Calcium phosphate cements (CPCs) have many favorable properties that support their clinical use as bone defect repair. However, it is difficult to deliver to the required site and hard to compact adequately due to inherently low ductility of ceramics. The aim of this study focused on the effect of the gelatin content on properties of CPCs. The diametral tensile strength, morphology, and weight loss of gelatin cements were evaluated after immersion in physiological solution, in addition to setting time. The results indicated that the setting time significantly increased with increasing gelatin amount. The 2 wt.% gelatin could make CPCs attain the maximum strength value of 2.1 MPa at 15-day immersion, while 1.6 MPa for the cement without gelatin. It is concluded that the presence of gelatin improved mechanical properties of CPCs; in particular, 2 wt.% gelatin. CPCs containing 2 wt.% gelatin hardened in an acceptable time recommended for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083642     DOI: 10.1016/j.actbio.2007.10.011

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  16 in total

Review 1.  Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.

Authors:  Susmita Bose; Solaiman Tarafder
Journal:  Acta Biomater       Date:  2011-11-20       Impact factor: 8.947

2.  In-situ hybridization of calcium silicate and hydroxyapatite-gelatin nanocomposites enhances physical property and in vitro osteogenesis.

Authors:  Chi-Kai Chiu; Dong Joon Lee; Hsin Chen; Laurence C Chow; Ching-Chang Ko
Journal:  J Mater Sci Mater Med       Date:  2015-02-04       Impact factor: 3.896

3.  Self-hardening calcium deficient hydroxyapatite/gelatine foams for bone regeneration.

Authors:  Edgar B Montufar; Tania Traykova; Etienne Schacht; Luigi Ambrosio; Matteo Santin; Josep A Planell; Maria-Pau Ginebra
Journal:  J Mater Sci Mater Med       Date:  2009-10-30       Impact factor: 3.896

4.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

5.  The synergistic effects of Chinese herb and injectable calcium silicate/β-tricalcium phosphate composite on an osteogenic accelerator in vitro.

Authors:  Ming-Hsien Huang; Chia-Tze Kao; Yi-Wen Chen; Tuan-Ti Hsu; Den-En Shieh; Tsui-Hsien Huang; Ming-You Shie
Journal:  J Mater Sci Mater Med       Date:  2015-03-19       Impact factor: 3.896

6.  Alginate combined calcium phosphate cements: mechanical properties and in vitro rat bone marrow stromal cell responses.

Authors:  Gil-Su Lee; Jeong-Hui Park; Jong-Eun Won; Ueon Sang Shin; Hae-Won Kim
Journal:  J Mater Sci Mater Med       Date:  2011-04-02       Impact factor: 3.896

7.  Addition of sodium hyaluronate and the effect on performance of the injectable calcium phosphate cement.

Authors:  Dan Kai; Dongxiao Li; Xiangdong Zhu; Lei Zhang; Hongsong Fan; Xingdong Zhang
Journal:  J Mater Sci Mater Med       Date:  2009-03-17       Impact factor: 3.896

8.  Creation of macroporous calcium phosphate cements as bone substitutes by using genipin-crosslinked gelatin microspheres.

Authors:  Meng Li; Xingyan Liu; Xudong Liu; Baofeng Ge; Keming Chen
Journal:  J Mater Sci Mater Med       Date:  2008-12-04       Impact factor: 3.896

9.  Properties of anti-washout-type calcium silicate bone cements containing gelatin.

Authors:  Chun-Cheng Chen; Meng-Heng Lai; Wei-Chung Wang; Shinn-Jyh Ding
Journal:  J Mater Sci Mater Med       Date:  2009-11-26       Impact factor: 3.896

10.  Kinetics of apatite formation on a calcium-silicate cement for root-end filling during ageing in physiological-like phosphate solutions.

Authors:  Maria Giovanna Gandolfi; Paola Taddei; Anna Tinti; Elettra De Stefano Dorigo; Piermaria Luigi Rossi; Carlo Prati
Journal:  Clin Oral Investig       Date:  2009-11-27       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.